Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 -0.0546
Stock impact report

ContraFect Announces Publication of Exebacase Data in Antimicrobial Agents and Chemotherapy Journal

ContraFect Corporation (CFRX) 
Last contrafect corporation earnings: 3/18 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.contrafect.com
Company Research Source: GlobeNewswire
YONKERS, N.Y., April 08, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of biologic therapies for life-threatening, drug-resistant infectious diseases, today announced that its manuscript titled “The Antistaphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood To Potentiate Methicillin-Resistant Staphylococcus aureus Bacteriolysis” was published in the April edition of the peer-reviewed Antimicrobial Agents and Chemotherapy Journal of the American Society of Microbiology. The manuscript highlights in vitro activity of exebacase (CF-301) in human blood versus in a conventional testing medium (cation-adjusted Mueller-Hinton broth (caMHB)), in which exebacase exhibited markedly higher potency (32 to =100-fold) in human blood versus caMHB in three standard microbiologic testing formats and demonstrated synergistic interaction with two key human blood factors. These results ult Show less Read more
Impact Snapshot
Event Time:
CFRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CFRX alerts
Opt-in for
CFRX alerts

from News Quantified
Opt-in for
CFRX alerts

from News Quantified